| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药商业(元) | 398,041,706.01 | 829,275,125.74 | 409,743,638.84 | 844,582,796.29 | 439,288,623.80 |
| 医药制造(元) | 450,089,844.83 | 1,123,095,191.19 | 551,106,207.88 | 1,204,225,654.34 | 671,077,411.65 |
| 营业成本(元) | |||||
| 医药商业(元) | 356,359,477.69 | 754,063,845.62 | 365,475,382.80 | 756,205,173.56 | 396,988,141.48 |
| 医药制造(元) | 118,619,119.96 | 317,618,430.40 | 145,299,577.01 | 318,861,539.39 | 187,216,163.82 |
| 毛利(元) | |||||
| 医药商业(元) | 41,682,228.32 | 75,211,280.12 | 44,268,256.04 | 88,377,622.73 | 42,300,482.32 |
| 医药制造(元) | 331,470,724.87 | 805,476,760.79 | 405,806,630.87 | 885,364,114.95 | 483,861,247.83 |
| 毛利率(%) | |||||
| 医药商业(%) | 10.47 | 9.07 | 10.80 | 10.46 | 9.63 |
| 医药制造(%) | 73.65 | 71.72 | 73.63 | 73.52 | 72.10 |
| 收入构成(%) | |||||
| 医药商业(%) | 46.93 | 42.48 | 42.64 | 41.22 | 39.56 |
| 医药制造(%) | 53.07 | 57.52 | 57.36 | 58.78 | 60.44 |
| 毛利构成(%) | |||||
| 医药商业(%) | 11.17 | 8.54 | 9.84 | 9.08 | 8.04 |
| 医药制造(%) | 88.83 | 91.46 | 90.16 | 90.92 | 91.96 |